Yelken, B. Et Al. 2015. Eculizumab for Treatment of Refractory Antibody-Mediated Rejection in Kidney Transplant Patients: A Single-Center Experience. TRANSPLANTATION PROCEEDINGS , vol.47, no.6 , 1754-1759.

Yelken, B., Arpali, E., Gorcin, S., Kocak, B., Karatas, C., Demiralp, E., ... TÜRKMEN, A.(2015). Eculizumab for Treatment of Refractory Antibody-Mediated Rejection in Kidney Transplant Patients: A Single-Center Experience. TRANSPLANTATION PROCEEDINGS , vol.47, no.6, 1754-1759.

Yelken, B. Et Al. "Eculizumab for Treatment of Refractory Antibody-Mediated Rejection in Kidney Transplant Patients: A Single-Center Experience," TRANSPLANTATION PROCEEDINGS , vol.47, no.6, 1754-1759, 2015

Yelken, B. Et Al. "Eculizumab for Treatment of Refractory Antibody-Mediated Rejection in Kidney Transplant Patients: A Single-Center Experience." TRANSPLANTATION PROCEEDINGS , vol.47, no.6, pp.1754-1759, 2015

Yelken, B. Et Al. (2015) . "Eculizumab for Treatment of Refractory Antibody-Mediated Rejection in Kidney Transplant Patients: A Single-Center Experience." TRANSPLANTATION PROCEEDINGS , vol.47, no.6, pp.1754-1759.

@article{article, author={B. Yelken Et Al. }, title={Eculizumab for Treatment of Refractory Antibody-Mediated Rejection in Kidney Transplant Patients: A Single-Center Experience}, journal={TRANSPLANTATION PROCEEDINGS}, year=2015, pages={1754-1759} }